Avillion appoints Dr Allison Jeynes-Ellis as Chief Executive Officer
18 February 2014 | By Avillion LLP
Avillion LLP announced it has appointed Dr Allison Jeynes-Ellis MB, ChB, FFPM as Chief Executive Officer...
List view / Grid view
News
Novartis expands cancer immunotherapy research program with acquisition of CoStim
17 February 2014 | By Novartis
Novartis announced that it is broadening its cancer immunotherapy research program with the acquisition of CoStim Pharmaceuticals Inc...
European Medicines Agency welcomes new Head of IT Development Department
17 February 2014 | By The European Medicines Agency
The European Medicines Agency is pleased to welcome Dina Tsiambaou as the new Head of IT Development Department in the Information Technology Division...
MSD Animal Health receives marketing authorization from European Commission for BRAVECTO™
17 February 2014 | By Merck
MSD Animal Health announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use, the European Commission has granted marketing authorization for the veterinary medicinal product BRAVECTO™...
Boehringer Ingelheim receives East Bay Innovation Award
17 February 2014 | By Boehringer Ingelheim
Boehringer Ingelheim Fremont Inc. received the East Bay Innovation Award in recognition for its contribution to the East Bay's culture of innovation...
William D. Young to retire from Biogen Idec’s Board of Directors
17 February 2014 | By Biogen Idec
Stelios Papadopoulos to become Chairman of the Board...
Daiichi Sankyo and UMN Pharma enter into collaborative research agreement for Norovirus Vaccine
14 February 2014 | By Daiichi Sankyo Company
Norovirus is one of the leading causes of infectious gastroenteritis and the number of infected people reported is increasing both in Japan and globally...
GSK announces start of Phase lll study for mepolizumab in patients with Eosinophilic Granulomatosis with Polyangiitis
14 February 2014 | By GlaxoSmithKline
GlaxoSmithKline announced the start of a Phase III study to evaluate the efficacy and safety of mepolizumab, an investigational IL-5 antagonist, in patients with Eosinophilic Granulomatosis with Polyangiitis...
Teva announces full FDA approval of SYNRIBO® (Omacetaxine Mepesuccinate) for injection
13 February 2014 | By Teva
24-month FDA post marketing commitment completed...
IMBRUVICA™ (ibrutinib) now approved in the U.S. for patients with chronic lymphocytic leukemia who have received at least one prior therapy
13 February 2014 | By Johnson & Johnson
Janssen Biotech, Inc. announced the U.S. Food and Drug Administration has approved IMBRUVICA™ (ibrutinib) capsules for the treatment of patients with chronic lymphocytic leukemia who have received at least one prior therapy...
EMA introduces product numbers to track medicines through pre-authorisation procedures
12 February 2014 | By The European Medicines Agency
The European Medicines Agency has introduced unique product identifiers (UPIs) to track medicines through pre-authorisation procedures...
Pfizer statement on joint meeting of FDA Advisory Committees
12 February 2014 | By Pfizer
Pfizer agrees with the recommendation of the joint meeting of the FDA Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee...
AbbVie expands manufacturing presence with US$320 million investment in Singapore
12 February 2014 | By AbbVie
AbbVie Inc. announces a US$320 million investment to establish operations in Singapore for small molecule and biologics active drug substance manufacturing...
High throughput nanoliter pipetting with Tecan’s MCA 384
11 February 2014 | By kdm communications
Scientists working at the Leibniz-Institute for Molecular Pharmacology (FMP) in Berlin, Germany, are benefitting from the low volume pipetting capability of a MultiChannel Arm™ (MCA) 384 for siRNA and small molecule screening...
Emperra appoints Christian Krey as new CEO to market ESYSTA® telediabetology system
11 February 2014 | By EMPERRA® GmbH
EMPERRA® GmbH E-Health Technologies announced the appointment of Dr. Christian Krey as Managing Director and CEO. Dr. Krey has many years of experience in the field of diabetes mellitus...
